RxNorm Names
UP AND UP FAMOTIDINE
(famotidine)
tablet
[Target Corporation]
Permanent Link:
http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ed8d76c0-3ba2-48b3-ad8b-9f1ea1bd0e41| Category | DEA Schedule | Marketing Status |
|---|---|---|
| HUMAN OTC DRUG LABEL | Abbreviated New Drug Application |
Uses
- •
- relieves heartburn associated with acid indigestion and sour stomach
- •
- prevents heartburn associated with acid indigestion and sour stomach brought on by eating or drinking certain food and beverages
Warnings
Allergy alert: Do not use if you are allergic to famotidine or other acid reducers
Do not use
- •
- if you have trouble or pain swallowing food, vomiting with blood, or bloody or black stools. These may be signs of a serious condition. See your doctor.
- •
- if you have kidney disease, except under the advice and supervision of a doctor
- •
- with other acid reducers
Ask a doctor before use if you have
- •
- had heartburn over 3 months. This may be a sign of a more serious condition.
- •
- heartburn with lightheadedness, sweating, or dizziness
- •
- chest pain or shoulder pain with shortness of breath; sweating; pain spreading to arms, neck or shoulders; or lightheadedness
- •
- frequent chest pain
- •
- frequent wheezing, particularly with heartburn
- •
- unexplained weight loss
- •
- nausea or vomiting
- •
- stomach pain
Directions
- •
- adults and children 12 years and over:
- •
- to relieve symptoms, swallow 1 tablet with a glass of water. Do not chew.
- •
- to prevent symptoms, swallow 1 tablet with a glass of water at any time from 10 to 60 minutes before eating food or drinking beverages that cause heartburn
- •
- do not use more than 2 tablets in 24 hours
- •
- children under 12 years: ask a doctor
Other information
- •
- read the directions and warnings before use
- •
- keep the carton. It contains important information.
- •
- store at 20°-25°C (68°-77°F)
- •
- protect from moisture and light
| UP AND UP FAMOTIDINE
famotidine tablet |
||||||||||||||||||||||||
|
||||||||||||||||||||||||
|
||||||||||||||||||||||||
|
||||||||||||||||||||||||
|
||||||||||||||||||||||||
|
||||||||||||||||||||||||
|
||||||||||||||||||||||||
| Labeler - Target Corporation (006961700) |
Revised: 01/2013
Document Id: ed8d76c0-3ba2-48b3-ad8b-9f1ea1bd0e41
Set id: ed8d76c0-3ba2-48b3-ad8b-9f1ea1bd0e41
Version: 1
Effective Time: 20130122
Target Corporation
Review RxNorm Normal Forms
